Van Leeuwenhoeck Research

VLR provides institutional investors and other professional investors with independent, un-biased research on the real value of innovative Life Sciences companies. Many institutional and individual investors will not invest in companies lacking independent third-party research coverage, yet few investment banks cover this sector because it requires dedicated expertise. In spite of the lack of quality

knowledge on an industry-wide basis, there is increased demand for life science-specific market research as investors are seeking information about leading companies in the sector in order to make well-informed investment decisions.

A subscription service provides detailed information on a wide selection of biotech companies that investors are tracking. This service is based on quarterly, in-depth research reports and a daily email service to keep subscribers informed about relevant news flow and issues that might trigger fluctuations in the price of the underlying securities.

The VLR team conducts fundamental financial research, independently from any specific broker, bank, or investor. A select circle of top analysts assist the firm in conducting fundamental biotech research according to the highest standards.

Investment banking firms, institutions, and individual investors retain VLR to obtain independent company equity research. The firm's research operations are similar to a research department of a major investment banking firm but without brokerage or investment banking operations. Unlike traditional brokerage firms that limit research distribution to clients in Exchange for commissions, VLR widely distributes its research to institutions and individuals within Europe and North America.